Are corticosteroids effective for prevention of scar formation after second-degree skin burn?

Journal of Dermatological Treatment

Volumn 25, Issue 4, 2014, Pages 360-362

  Taheri, Arash ^a   Mansoori, Parisa ^a   Al Dabagh, Amir ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Glucocorticoid; Inflammation; Keloid; Steroid; Ulcer

Indexed keywords

CORTICOSTEROID; HYALURONIDASE; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

BURN; CARBON DIOXIDE LASER; CORTICOSTEROID THERAPY; DRUG EFFICACY; EPITHELIZATION; HUMAN; HYPERTROPHIC SCAR; KELOID; META ANALYSIS; OINTMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RECURRENT DISEASE; REVIEW; SCAR FORMATION; SKIN BIOPSY; SUTURE REMOVAL; SYSTEMATIC REVIEW; WOUND HEALING;

BURNS; CICATRIX; GLUCOCORTICOIDS; HUMANS; SKIN; WOUND HEALING;

EID: 84890420760     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2013.806768     Document Type: Review

References (24)

1. Burn Incidence and Treatment in the United States: 2011 Fact Sheet. 2012. American Burn Association. http://www.ameriburn.org/resources factsheet.php
2. Lawrence JW, Mason ST, Schomer K, Klein MB. Epidemiology and impact of scarring after burn injury: A systematic review of the literature. J Burn Care Res. 2012;33:136-146
3. Ashley FL. Atrophy following cortisone injection for hypertrophic scar. Calif Med. 1973;119:65-66
4. Mustoe TA, Cooter RD, Gold MH, Hobbs FD, Ramelet AA, Shakespeare PG, et al. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110:560-571
5. Hayashi T, Furukawa H, Oyama A, Funayama E, Saito A, Murao N, et al. A new uniform protocol of combined corticosteroid injections and ointment application reduces recurrence rates after surgical keloid/hypertrophic scar excision. Dermatol Surg. 2012;38: 893-897
6. Berman B, Flores F. Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. J Am Acad Dermatol. 1997;37:755-757
7. Chowdri NA, Masarat M, Mattoo A, Darzi MA. Keloids and hypertrophic scars: Results with intraoperative and serial postoperative corticosteroid injection therapy. Aust N Z J Surg. 1999;69:655-659
8. Kauh YC, Rouda S, Mondragon G, Tokarek R, diLeonardo M, Tuan RS, et al. Major suppression of pro-Alpha1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol. 1997;37:586-589
9. Sclafani AP, Gordon L, Chadha M, Romo T 3rd. Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy: A randomized, prospective study and review of the literature. Dermatol Surg. 1996;22:569-574
10. Stucker FJ, Shaw GY. An approach to management of keloids. Arch Otolaryngol Head Neck Surg. 1992;118:63-67
11. Shons AR, Press BH. The treatment of earlobe keloids by surgical excision and postoperative triamcinolone injection. Ann Plast Surg. 1983;10:480-482
12. Tang YW. Intra-And postoperative steroid injections for keloids and hypertrophic scars. Br J Plast Surg. 1992;45:371-373
13. Rosen DJ, Patel MK, Freeman K, Weiss PR. A primary protocol for the management of ear keloids: Results of excision combined with intraoperative and postoperative steroid injections. Plast Reconstr Surg. 2007; 120:1395-1400
14. Broughton G, Janis JE, Attinger CE. Wound healing: An overview. Plast Reconstr Surg. 2006;117:1e-32e
15. Shih B, Garside E, McGrouther DA, Bayat A. Molecular dissection of abnormal wound healing processes resulting in keloid disease. Wound Repair Regen. 2010;18:139-153
16. Kondo T, Ishida Y. Molecular pathology of wound healing. Forensic Sci Int. 2010;203:93-98
17. Profyris C, Tziotzios C, Do Vale I. Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics Part I. The molecular basis of scar formation. J Am Acad Dermatol. 2012;66: 1-10
18. Moulin V, Larochelle S, Langlois C, Thibault I, Lopez-Vallé CA et al. Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors. J Cell Physiol. 2004; 198:350-358
19. Wolfram D, Tzankov A, Pulzl P, Piza-Katzer H. Hypertrophic scars and keloids-A review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg. 2009;35:171-181
20. Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic scarring and keloids: Pathomechanisms and current and emerging treatment strategies. Mol Med. 2011;17:113-125
21. Wang J, Hori K, Ding J, Huang Y, Kwan P, Ladak A. Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring. J Cell Physiol. 2011;226:1265-1273
22. Fassler R, Sasaki T, Timpl R, Chu ML, Werner S. Differential regulation of fibulin, tenascin-C, and nidogen expression during wound healing of normal and glucocorticoid-Treated mice. Exp Cell Res. 1996; 222:111-116
23. Nauck M, Roth M, Tamm M, Eickelberg O, Wieland H, Stulz P. Induction of vascular endothelial growth factor by platelet-Activating factor and platelet-derived growth factor is downregulated by corticosteroids. Am J Respir Cell Mol Biol. 1997;16:398-406
24. Kauh YC, Rouda S, Mondragon G, Tokarek R, diLeonardo M, Tuan RS. Major suppression of pro-Alpha1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol. 1997;37:586-589